Miju Co., Ltd. (XKON:351020)
South Korea · Delayed Price · Currency is KRW 8,390.00
+240.00 (2.94%)
At close: Mar 6, 2026
Miju Co., Ltd. Revenue
In the year 2021, Miju Co., Ltd. had annual revenue of 18.32B KRW with 23.29% growth.
Revenue
18.32B
Revenue Growth
+23.29%
P/S Ratio
0.95
Revenue / Employee
n/a
Employees
n/a
Market Cap
17.41B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2021 | 18.32B | 3.46B | 23.29% |
| Dec 31, 2020 | 14.86B | -204.16B | -93.22% |
| Dec 31, 2019 | 219.02B | 150.52B | 219.76% |
| Dec 31, 2018 | 68.50B | -148.96B | -68.50% |
| Dec 31, 2017 | 217.45B | 20.05B | 10.16% |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AHA Co.,Ltd. | 83.97B |
| Tae Yang 3C | 60.00B |
| NSM Co., Ltd. | 49.66B |
| Kwangdong Healthbio | 38.10B |
| Emb Co.,Ltd. | 33.99B |
| KONASOL | 17.20B |
| Median Diagnostics | 7.86B |
| LAT Co.,Ltd. | 6.89B |